Meetings/Workshops on Genomics and Bioinformatics in the United States (USA)

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

1.
 
Keystone Symposia: Cell Plasticity within the Tumor Microenvironment
ID
828524
Dates
08 Jan 2017 - 12 Jan 2017
Location
Big Sky, Montana, United States
Abstract
Scholarship & Discounted Abstract Deadline: Sep 13, 2016; Abstract Deadline: Oct 6, 2016; Discounted Registration Deadline: Nov 8, 2016

During the last decade, it has become unequivocally evident that tumor development is not a cell-autonomous process but rather depends on the intricate reciprocal interplay of mutant tumor cells with their local and distant environments. Composition and polarization of cells in the tumor microenvironment depends on genetic as well as environmental factors and is directly influenced by tumor therapy. Indeed, therapies that aim to shape the local immune milieu and consecutive signaling pathways in both stromal and tumor/stem cells address the complex pathophysiology of tumors more adequately and may therefore add substantial benefits for therapy. An absolute pre-requisite for such an endeavor is a comprehensive understanding of the exact molecular basis of the complex signaling networks in the tumor microenvironment that control the plasticity of both stromal and tumor cells, thereby shaping the complex cellular contexture, which ultimately forms a pro- or anti-tumorigenic milieu. Thus, this symposium aims to gather a comprehensive functional understanding of mediator-dependent cellular and molecular events that are responsible for the plasticity of both stromal and tumor/stem cells. It will bring together experts in cancer, stromal and immune cells to synthesize scientific knowledge about the phenomenon of cell plasticity within the tumor microenvironment, to define molecular and cellular pathways mediating plasticity and to propose approaches to interfere with cell plasticity for a new generation of effective therapeutic approaches in cancer and chronic injury. Importantly, it will bring together interdisciplinary groups of scientists or investigators who normally would not have an opportunity to meet (classical cancer biologists, tumor immunobiologists, stem cell experts and scientists working on stromal cells).

Contact
Attendee Services;     Phone: [970-262-1230];     Email: info@keystonesymposia.org
Topics
Cancer, tumor immunology, basic mechanisms
Related subject(s)
2.
 
Keystone Symposia: Precision Genome Engineering
ID
828501
Dates
08 Jan 2017 - 12 Jan 2017
Location
Breckenridge, Colorado, United States
Abstract
Precision genome engineering technologies enable targeted, highly efficient alteration of DNA sequences in living cells or organisms. Given their customizable nature, these technologies promise to be broadly useful both as biomedical research tools and as novel therapeutics for gene-based diseases. Given the rapidity with which this field moves, it is challenging for both newcomers and experts alike to stay updated with all of the latest advances. Furthermore, genome engineering necessarily encompasses a broad range of scientific expertise that includes fundamental mechanisms of DNA repair, basic science studies of bacterial-derived systems that form the basis of many of these technologies, innovations with genome engineering tool platforms, a wide variety of research applications spanning from model organisms to plants and mammalian cells, and pre-clinical and clinical studies aimed at translation into human therapeutics. The goal of this Keystone Symposia meeting is to bring together scientists from academia and industry with diverse but relevant expertise in a setting conducive to discussion of new results and potential collaborative efforts. Invited talks will cover a wide range of topics ranging from fundamental basic science through to clinical translation studies. Attendees of this meeting will have the opportunity to hear about the latest findings in this fast-paced field and to establish collaborations with scientists who have complementary expertise.
Contact
Attendee Services;     Phone: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Molecular biology, precision medicine, transcription, translational expression, genetics, genomics
Related subject(s)
3.
 
Keystone Symposia: Transcriptional and Epigenetic Control in Stem Cells
ID
828779
Dates
08 Jan 2017 - 12 Jan 2017
Location
Olympic Valley, California, United States
Abstract
Scholarship & Discounted Abstract Deadline: Sep 14, 2016; Abstract Deadline: Oct 10, 2016; Discounted Registration Deadline: Nov 9, 2016

The objective of this meeting is to bring together leaders in the field to discuss latest advances in stem cell biology with an emphasis on transcriptional and epigenetic mechanisms of gene regulation in pluripotent and neural stem cells. It will elucidate the roles of transcriptional regulators and chromatin structure in defining stem cell identity. These presentations will be complemented by talks on experimentally induced cell fate changes during reprogramming to pluripotency and transdifferentiation into various cell lineages. We will further discuss efforts to capture distinct stem cell types and states from the preimplantation embryo including naïve human embryonic stem cells. Advances in pluripotent stem cells will be compared and contrasted with recent insights into the biology of neural stem cells, including discussions of their origin, specification and turnover. Lastly, two sessions dedicated to disease modeling and cell therapy, respectively, will highlight ongoing attempts to study and treat diseases using stem cells from the hematopoietic and neural systems. This meeting is being held jointly with

Contact
Attendee Services;     Phone: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
genetics, genomics, development, stem cells,
Related subject(s)
4.
 
Keystone Symposia: Omics Strategies to Study the Proteome
ID
833029
Dates
29 Jan 2017 - 02 Feb 2017
Location
Seattle, Washington, United States
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
5.
 
Keystone Symposia: Epigenetics and Human Disease – Progress from Mechanisms to Therapeutics
ID
832940
Dates
29 Jan 2017 - 02 Feb 2017
Location
Seattle, Washington, United States
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genetics, genomics, basic mechanisms, molecular biology, cancer
Related subject(s)
6.
 
Keystone Symposia: Inflammation-Driven Cancer – Mechanisms to Therapy
ID
833469
Dates
05 Feb 2017 - 09 Feb 2017
Location
Keystone, Colorado, United States
Abstract
Carcinogenesis is the result of a complex interplay of cell intrinsic and extrinsic processes that promote genomic instability, sustained proliferation, resistance to apoptosis, reprogramming and reorganization of the stromal environment. An immune cell infiltrate is a characteristic feature of many tumors, and it is increasingly appreciated that immunity and inflammation are key determinants of tumor development and progression. This meeting will consider the molecular and environmental factors that shape the extensive cross-talk between immune, stromal and cancer cells in the tumor microenvironment. Positioned at the interface of cancer cell signaling, stem cells, inflammatory pathways and microbial drivers, this meeting should provide new insights into the factors that control the balance between tumor-promoting and tumor-suppressive immunity and inflammation and how this can be applied in the prevention and treatment of cancer. The meeting will attract a multi-disciplinary group of cancer cell biologists, immunologists and inflammation biologists and will be of interest to basic and clinical scientists alike.
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
cancer, translational medicine, inflammation, immunology, stem cells, cell signaling
Related subject(s)
7.
 
Keystone Symposia: Microbiome in Health and Disease
ID
833446
Dates
05 Feb 2017 - 09 Feb 2017
Location
Keystone, Colorado, United States
Abstract
This Keystone Symposia meeting brings together experts in clinical medicine, clinical microbiology, microbial genomics, and bacterial genetics to explore how both strain variation and underlying microbial community determine health and disease. Genomic advances provide higher-level resolution to both pathogen and host genetic determinants. This meeting aims to explore how monitoring and potentially altering the microbial community may modulate and predict disease risk. This conference is being held jointly with
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
metabolic diseases, microbiology, microbial genomics, bacterial genetics, inflammation
8.
 
GeneMed-2017 — International Conference on Genomic Medicine
ID
797007
Dates
22 Feb 2017 - 24 Feb 2017
Location
Baltimore, Maryland, United States
Abstract
Genomic analysis is rapidly becoming an important tool in biomedical research for study of Future Medicine and health. So focusing on the scope of Genomic Medicine we are organizing this conference to gather top global researchers, leaders and innovators to announce new discoveries, cutting edge breakthroughs.

Its 3 day event which includes Keynote sessions, featured speakers, students, companies. We encourage delegates to use this conference as a meeting place to assemble their academic interest-groups for global deliberations.

Contact
Sushma Bandi;     Phone: [408-426-4833];     Email: genemed@uniscigroup.org
Topics
Genome Technologies, Next Generation Sequencing, Precision and Personalized Medicine, Epigenetics, Biomarkers, Bioinformatics, Diagnostic and Therapeutic issues, Sequencing technologies and Techniques, Structural and Functional Genomics, Molecular Pathology, Plant Genomics and Microbiome, Human Genomics, Genetic Medicine, Immunogenomics
9.
 
Frontiers in Cancer Immunotherapy
ID
824469
Dates
27 Feb 2017 - 28 Feb 2017
Location
New York, NY, United States
Abstract
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Topics
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Related subject(s)
10.
 
Keystone Symposia: Rare and Undiagnosed Diseases: Discovery and Models of Precision Therapy
ID
833351
Dates
05 Mar 2017 - 08 Mar 2017
Location
Boston, Massachusetts, United States
Abstract
Of the 7000 known rare diseases, only a fraction have their molecular and mechanistic bases delineated, and many other diseases have yet to be discovered. Characterization of these disorders will reveal new biochemical pathways and cell biological processes, point to potential drug targets, and provide hope for millions of affected individuals. This meeting will address approaches and best practices in pursuing rare and undiagnosed disorders, limitations in data sharing as a barrier to new disease discovery, and examples of successful descriptions of new diseases, mechanisms, and treatments. Specific aims include fostering the development of expertise in rare diseases and the definition of their natural histories; an international network of scientists and physicians collaborating on new disease discovery by sharing phenotypic and sequence data; and new therapeutic approaches based upon rare and new disease mechanisms. Through this meeting, participants should become familiar with rare and undiagnosed disease programs, acquire insights into new disease mechanisms, learn about potential therapeutic targets, and establish collaborations that enhance rare disorder expertise and new disease discovery. The meeting will bring together physicians who are expert in rare disorders with scientists who know metabolic pathways and mechanisms, advancing understanding and therapy. A desired outcome of the meeting includes developing lists of clinical and basic research experts for synergistic collaborations, and creating an international organization to perpetuate the joint investigation of rare and new diseases.
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genomics, genetics, neurobiology, neurodegenerative disease, physiology
Related subject(s)
11.
 
BICOB-2017 — 9th International Conference on Bioinformatics and Computational Biology
ID
842901
Dates
20 Mar 2017 - 22 Mar 2017
Location
Honolulu, HI,, United States
Abstract
Most research areas of bioinformatics, computational biology and medical informatics have experienced significant advances in recent years driven by computational techniques in bioinformatics. The 9th International Conference on Bioinformatics and Computational Biology (BICOB) will provide an utmost venue for researchers and practitioners in bioinformatics to present and publish their research results and techniques. Bioinformatics and computational biology continue to be a vibrant research area with broadening applications and new emerging challenges. BICOB-2017 seeks original and high quality papers in the fields of bioinformatics, computational biology, systems biology, medical informatics and the related areas. The conference includes a Best Paper Award to be given during the conference banquet. We also encourage work in progress and research results in the emerging and evolutionary computational areas. Work in the computational methods related to, or with application in, bioinformatics is also encouraged including: computational intelligence and its application in bioinformatics, bio-data mining and text mining, evolutionary algorithms, nature-inspired computation, machine learning and bio-NLP, biomedical ontology, biomathematics, modeling and simulation, pattern recognition, data visualization, biostatistics.
Contact
Email: isca@isca-hq.org.
Topics
Bioinformatics and Computational Biology
Event website
12.
 
Keystone Symposia - RNA-Based Approaches in Cardiovascular Disease
ID
825414
Dates
26 Mar 2017 - 30 Mar 2017
Location
Keystone, Colorado, United States
Abstract
Cardiac diseases are the leading cause of death worldwide. RNA-based mechanisms and therapeutic approaches are emerging fields in cardiovascular science. This meeting will present and discuss latest developments using both coding RNA and noncoding RNA (such as microRNAs, long noncoding RNAs and circular RNAs) -based approaches to better understand and develop new therapeutic strategies for cardiac diseases. Attendees will benefit from workshops, specific sessions and industrial perspectives covering everything from basic science to clinical translation employing RNA therapeutics in cardiovascular medicine.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Cardiovascular Disease, RNA-Based Mechanisms, Cardiovascular Development, RNA Research, RNA Diagnostics, Paracrine Effects, Noncoding RNA Therapeutics, RNA Detection, Cardiovascular Regeneration, RNA Therapeutics, Cardiovascular Repair Mechanisms
Related subject(s)
13.
 
Keystone Symposia - DNA Replication and Recombination
ID
825194
Dates
02 Apr 2017 - 06 Apr 2017
Location
Santa Fe, New Mexico, United States
Abstract
DNA replication and recombination are common to all cells. Errors in these processes lead to many diseases in humans, including cancer, and many fundamental questions are still unresolved. Due to recent technical advances in microscopy and other techniques, these dynamic processes can now be studied in time and space in both prokaryotes and eukaryotes. Moreover, breakthroughs in the biochemical reconstitution of processes in DNA replication and recombination repair as well as single particle electron microscopy promise to reveal new mechanisms at near-atomic resolution; and new DNA sequencing technologies make it possible to study these key processes in great details. Mechanistic similarities across the three domains of life provide new basic principles while differences identify potential targets for therapeutic intervention.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genomic Instability, DNA Repair, DNA Replication/Repair Structure, DNA function, Chromatin Structure, DNA Replication/Repair, Regulating Recombination, Replication Fork Progression, Replication Initiation Mechanisms, Replication Coupled Repair,
14.
 
Keystone Symposia - Genomic Instability and DNA Repair
ID
825359
Dates
02 Apr 2017 - 02 Jun 2017
Location
Santa Fe, New Mexico, United States
Abstract
Genome stability is the foundation upon which all cellular and organismal processes depend. This conference will grapple with the intricate array of biochemical reactions orchestrated by the cell to replicate, repair and segregate chromosomes accurately despite constant threats from spontaneous and environmentally-induced damage. Defects in these reactions lead to genomic instability, a confirmed driver of cancer and degenerative diseases. Fascinating and therapeutically crucial questions remain about the mechanisms underlying chromosome stability, and cross-disciplinary approaches are required to address them. How do epigenetic chromatin marks influence repair of underlying DNA sequences, and how can we predict the effects of chemotherapeutic agents that alter such marks? To what extent is the nucleus organized into subdomains with distinct functions; how are these subdomains altered when cells move or differentiate? How are the myriad helicases, nucleases and polymerases coordinated to safeguard genome stability, why are these molecules often mutated in human disease, and how can we ameliorate the effects of such mutations? What is the array of strategies available to cancer cells as they achieve unlimited proliferation? This conference has a history of bringing together investigators from diverse subfields who otherwise rarely meet. Cutting-edge concepts in translational, genomic, cellular, molecular, RNA and structural biology will be dissected to take the conversation to unprecedented levels of depth and breadth. The concurrent conference on “DNA Replication and Recombination” will provide additional opportunities for cross-talk. Both conferences are committed to nurturing interactions among longtime experts in the field with students, postdocs and investigators new to the field.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genomic Instability, DNA Repair, RNA Metabolism, Chromatin Structure, DNA Replication/Repair, Nuclear Dynamics, Cell Cycle Regulation, DNA Damage Response, Replication Coupled Repair, Telomeres, Centromeres
Related subject(s)
15.
 
Genome Editing USA Congress 2016
ID
853023
Dates
10 May 2017 - 11 May 2017
Location
Boston, United States
Abstract
Oxford Global is proud to present the Genome Editing USA Congress, on the 10th-11th May 2017 in Boston. Over two days our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss therapeutic and drug discovery applications, as well as novel gene-editing techniques and technologies. This event provides an ideal platform to participate in formal 1-2-1 meetings and informal networking drinks with other key industry figures. The event will be co-located with our Advances in Transgenic Technology Congress.
Contact
Danielle Dalby;     Phone: [+44 1865 248455];     Email: d.dalby@oxfordglobal.co.uk
Topics
genome editing, genetics, transgenic, therapeutic applications of genome editing
Related subject(s)
16.
 
Advances in Transgenic Technology Congress 2017
ID
853378
Dates
10 May 2017 - 11 May 2017
Location
Boston, United States
Abstract
Oxford Global Conferences are proud to present our unmissable Advances in Transgenic Technology Congress, taking place on the 10th and 11th of May 2017, in Boston, US. Over 200 senior level attendees will cover the hottest topics for transgenic technologies. Day one will discuss updates in advances in transgenic genome editing, animal biotechnology: discovery & development in our technology focused workshops. Day two will focus on genetics and novel implantation and injection systems.
Contact
Danielle Dalby;     Phone: [+44 (0) 1865 248 455];     Email: d.dalby@oxfordglobal.co.uk
Topics
transgenic technology, transgenic models, genome editing, genome analysis, genomics
Related subject(s)

View all listed conferences in the United States (USA).

RNA Therapeutics conference

Good to know...

You can advertise your event or services in this space.

Last updated: 27 November 2016